Modica P A, Tempelhoff R, White P F
Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO 63110.
Anesth Analg. 1990 Apr;70(4):433-44. doi: 10.1213/00000539-199004000-00016.
Perioperative seizures have numerous potential etiologies. In general, when seizures occur during surgery, their onset often coincides with the introduction of a specific anesthetic or analgesic drug. Conversely, postoperative seizures are more commonly due to nonanesthetic causes. However, there have been reports of postoperative convulsions that appeared to be caused by anesthetic or analgesic drugs administered intraoperatively via inhalation or injection (e.g., intravenous, epidural, or peripheral nerve block). Some anesthetics appear to possess both proconvulsant and anticonvulsant properties. One possible factor is an inherent pharmacodynamic variability in the responsiveness of inhibitory and excitatory target tissues in the CNS. This is well illustrated by the anticonvulsant and proconvulsant effects of progressively higher doses of local anesthetic drugs. This variability in neuronal responsiveness could also explain the conflicting findings for low versus high doses of fentanyl and etomidate. Furthermore, biological variation in the individual patient's responsiveness to certain anesthetic drugs could be an additional contributory factor. Differing structure-activity relationships might also explain why some anesthetic agents possess both proconvulsant and anticonvulsant properties. Relatively minor modifications in a drug's structure can influence its affinity for a specific receptor site and its intrinsic pharmacologic activity. For example, when methohexital was first introduced, convulsions were commonly encountered in patients with and without a history of epilepsy. Subsequent fractionation of the original compound into its two isomeric forms resulted in the identification of the isomer primarily responsible for this convulsive activity. In its present formulation (Brevital; Eli Lilly, Indianapolis, Ind.), the epileptogenic properties of methohexital are limited to patients with psychomotor epilepsy. However, compared with thiopental, excitatory effects are still more common with methohexital. The excitatory effects of methohexital are presumably due to its methylated structure. The inhaled anesthetic flurothyl (hexaflurodiethyl) ether and the intravenous anesthetic ketamine also illustrate how subtle changes in stereoisomerism can result in significant changes in structure-activity relationships. Flurothyl, a fluorinated ether analogue, reliably produces convulsions in nonepileptic patients, whereas its structural isomer isoindoklon has not been associated with seizure activity. Other examples of isomer or structural analogue relationships that produce differential effects on neuronal hyperexcitability include enflurane-isoflurane and meperidine-normeperidine. In conclusion, the patient population (epileptic or nonepileptic), the method of documentation (EEG study or clinical observation), and the method of EEG analysis (cortical or depth electrodes) must be considered to properly analyze the proconvulsant and/or anticonvulsant properties of an anesthetic or analgesic drug.(ABSTRACT TRUNCATED AT 400 WORDS)
围手术期癫痫发作有众多潜在病因。一般来说,手术期间癫痫发作时,其发作往往与某种特定麻醉药或镇痛药的使用同时发生。相反,术后癫痫发作更常见的原因是非麻醉因素。然而,有报告称术后惊厥似乎是由术中通过吸入或注射(如静脉、硬膜外或外周神经阻滞)给予的麻醉药或镇痛药引起的。一些麻醉药似乎兼具促惊厥和抗惊厥特性。一个可能的因素是中枢神经系统中抑制性和兴奋性靶组织反应性存在固有的药效学变异性。局部麻醉药剂量逐渐增加时的抗惊厥和促惊厥作用很好地说明了这一点。神经元反应性的这种变异性也可以解释芬太尼和依托咪酯低剂量与高剂量时相互矛盾的研究结果。此外,个体患者对某些麻醉药反应性的生物学差异可能是另一个促成因素。不同的构效关系也可能解释为什么一些麻醉药兼具促惊厥和抗惊厥特性。药物结构相对较小的改变会影响其对特定受体位点的亲和力及其内在药理活性。例如,美索比妥最初应用时,有癫痫病史和无癫痫病史的患者都常出现惊厥。随后将原始化合物分离为两种异构体形式,确定了主要导致这种惊厥活性的异构体。在其目前的制剂(Brevital;礼来公司,印第安纳波利斯,印第安纳州)中,美索比妥的致癫痫特性仅限于精神运动性癫痫患者。然而,与硫喷妥相比,美索比妥的兴奋作用仍然更常见。美索比妥的兴奋作用可能归因于其甲基化结构。吸入麻醉药氟乙(六氟二乙醚)和静脉麻醉药氯胺酮也说明了立体异构的细微变化如何导致构效关系的显著改变。氟乙是一种氟化醚类似物,能可靠地使非癫痫患者发生惊厥,而其结构异构体异吲哚酮则与癫痫发作活动无关。对神经元兴奋性产生不同影响的异构体或结构类似物关系的其他例子包括恩氟烷 - 异氟烷和哌替啶 - 去甲哌替啶。总之,为了正确分析麻醉药或镇痛药的促惊厥和/或抗惊厥特性,必须考虑患者群体(癫痫或非癫痫)、记录方法(脑电图研究或临床观察)以及脑电图分析方法(皮层电极或深部电极)。(摘要截选至400字)